CAPOTEN Safety Questions, CAPOTEN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about CAPOTEN. Our extensive database of CAPOTEN adverse events and CAPOTEN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about CAPOTEN
CAPOTEN Safety Reports
Total CAPOTEN reports: 7.CAPOTEN FDA safety alerts: No.
Reported hospitalizations: 4.
Take CAPOTEN Side Effects Survey or Share Your CAPOTEN Story. CAPOTEN Usage.
Consumer or non-health professional from BRAZIL reported CAPOTEN problem on Feb 06, 2007. Female patient, 92 years of age, was diagnosed with hypertension, blood potassium decreased and was treated with CAPOTEN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, feeling abnormal, hypoaesthesia, muscle twitching. CAPOTEN dosage: unknown. During the same period patient was treated with HIGROTON, ALDOMET. Patient recovered.
CAPOTEN problem was reported by a Consumer or non-health professional from BRAZIL on Apr 17, 2007. Male patient, weighting 209.4 lb, was diagnosed with hypertension and was treated with CAPOTEN. After drug was administered, patient experienced the following problems/side effects: hypertension, infusion related reaction, ischaemia. CAPOTEN dosage: 50 MG QD ORAL. During the same period patient was treated with NIFEDIPINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported CAPOTEN problem on May 18, 2007. Male patient was diagnosed with hypertension and was treated with CAPOTEN. After drug was administered, patient experienced the following problems/side effects: dizziness, dysgeusia, hypertension, malaise. CAPOTEN dosage: 150 MG QD ORAL. During the same period patient was treated with LASIX. Patient was hospitalized. Patient recovered.
CAPOTEN problem was reported by a Physician from ITALY on July 10, 2006. Male patient, 74 years of age, was diagnosed with cardiac failure and was treated with CAPOTEN. After drug was administered, patient experienced the following problems/side effects: hepatitis cholestatic, toxic skin eruption. CAPOTEN dosage: 6.25 MG TID PO. During the same period patient was treated with LASIX, NITRAKET, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported CAPOTEN problem on Aug 17, 2006. Female patient, 36 years of age, was diagnosed with hypertension and was treated with CAPOTEN. After drug was administered, patient experienced the following problems/side effects: pruritus, rash, urticaria. CAPOTEN dosage: 6.25MG PO X1. Patient recovered.
CAPOTEN problem was reported by a Consumer or non-health professional from BRAZIL on Aug 11, 2006. Female patient, 56 years of age, weighting 187.4 lb, was diagnosed with hypertension and was treated with CAPOTEN. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, cerebrovascular accident, leishmaniasis. CAPOTEN dosage: unknown. During the same period patient was treated with CAPTOPRIL, HYDROCHLOROTHIAZIDE. Patient recovered.
Physician from BRAZIL reported CAPOTEN problem on Nov 30, 2006. Male patient, child 6 years of age, weighting 41.89 lb, was treated with CAPOTEN. After drug was administered, patient experienced the following problems/side effects: accidental exposure, hospitalisation, no adverse effect. CAPOTEN dosage: unknown. Patient was hospitalized. Patient recovered.